Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Carroll

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|December 13, 2019
Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping proceduresJohn Ouyang, Peter Zhang, Kevin J Carroll, et al.
Journal of Medical Microbiology|April 18, 2019
The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public healthKevin J Carroll, Lisa Harvey-Vince, Claire Jenkins, et al.
Advances in Therapy|November 12, 2025
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-analysis and Discussion of Appropriate MethodologyNicolas Maillard, Khalil El Karoui, Alex Mercer, et al.
AAPS Pharmscitech|August 19, 2021
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence TestingElise Burmeister Getz, Kevin J Carroll, Johanna Mielke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca PharmaceuticalsLaurence Collette, Tomasz Burzykowski, Kevin J Carroll, et al.
Child Psychiatry and Human Development|March 19, 2024
Theory of Mind and Social Informant Discrepancy in AutismAlister S Collins, Kevin J Carroll, Alan H Gerber, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trialsHarold Nelson, Catherine Bonuccelli, Finn Radner, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 3, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experienceJohn L Berk, Kevin J Carroll, Jorge Mejia Baranda, et al.
Statistics in Medicine|May 21, 2025
A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent EventsThomas R Fleming, Kevin J Carroll, Janet T Wittes, et al.
AAPS Pharmscitech|August 19, 2021
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch VariabilityElise Burmeister Getz, Kevin J Carroll, J David Christopher, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|December 13, 2019
Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping proceduresJohn Ouyang, Peter Zhang, Kevin J Carroll, et al.
Journal of Medical Microbiology|April 18, 2019
The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public healthKevin J Carroll, Lisa Harvey-Vince, Claire Jenkins, et al.
Advances in Therapy|November 12, 2025
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-analysis and Discussion of Appropriate MethodologyNicolas Maillard, Khalil El Karoui, Alex Mercer, et al.
AAPS Pharmscitech|August 19, 2021
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence TestingElise Burmeister Getz, Kevin J Carroll, Johanna Mielke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca PharmaceuticalsLaurence Collette, Tomasz Burzykowski, Kevin J Carroll, et al.
Child Psychiatry and Human Development|March 19, 2024
Theory of Mind and Social Informant Discrepancy in AutismAlister S Collins, Kevin J Carroll, Alan H Gerber, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trialsHarold Nelson, Catherine Bonuccelli, Finn Radner, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 3, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experienceJohn L Berk, Kevin J Carroll, Jorge Mejia Baranda, et al.
Statistics in Medicine|May 21, 2025
A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent EventsThomas R Fleming, Kevin J Carroll, Janet T Wittes, et al.
AAPS Pharmscitech|August 19, 2021
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch VariabilityElise Burmeister Getz, Kevin J Carroll, J David Christopher, et al.
Pageof 3